Protesters ready in case Trump refuses to accept election result
After chaotic term, 'Trump Doctrine' remakes US approach to world
Radio personality Rush Limbaugh is one of the nation’s most prominent conservative commentators and has a multimillion dollar net worth.
President Trump cut the interview short by about 15 minute before jumping on Twitter to make fun of host Lesley Stahl and her crew.
Melania Trump decided to cancel her attendance at a campaign rally for her husband, President Donald Trump, due to a lingering cough. The POTUS and FLOTUS tested positive for coronavirus earlier this month.
Oil giant Exxon Mobil refuted recent comments by President Donald Trump on Monday, as he boasted of his fundraising abilities in a tough race against Joe Biden.
Exposed: US pundit latest to fall foul of nude Zoom mishap
US lawmakers more optimistic on stimulus as deadline looms
US seeks to sway Brazil on Chinese 5G with $1-bn deal
A poll worker thought a law banning candidate/party names applied to the slogan.
US, Russia edge back towards talks on nuclear arms pact
With a record number of mail-in ballots being requested leading up to the presidential election, here's how to make sure your vote counts.
Trump demanded the attorney general mount an investigation against Biden's son and release the results before Election Day.
US officials set for final stimulus talks as deadline looms
Here's what parents need to know about masks on trick-or-treaters in 2020.
Sudan eyes economic recovery after planned US terror delisting
He was first diagnosed in February, and had previously said that his cancer was going in the right direction.
After Tiffany Trump’s viral appearance on the campaign trail, Miley Cyrus fans are clamoring for the singer to portray the President’s daughter on “Saturday Night Live.”
A review of the scandal surrounding Vice President Joe Biden's son, Hunter, is a mysterious plot we try to unravel.
She is slated to make a physical appearance today, but still won't make any solo remarks.
Scientists raise alarm over signs of vaccine 'hesitancy'
It hopes to get initial phase three trial results in November, putting an emergency FDA approval in December. Pfizer's timeline is similar.